Searchable abstracts of presentations at key conferences in endocrinology

ea0094p190 | Bone and Calcium | SFEBES2023

Parenteral bisphosphonate therapy is effective and safe when given prior to parathyroid surgery in severe primary hyperparathyroidism

Maarouf Amro , Winfield Jessica , Hazlehurst Jonathan , Joseph Sonia , Shepherd Lisa , Rahim Asad , Juszczak Agata

Background: Primary hyperparathyroidism may severely manifest with an adjusted calcium >3.5mmol/l and increased risk of prolonged postoperative hypocalcaemia. Formal consensus on preoperative optimisation appears lacking, especially around the utility of parenteral bisphosphonate treatment. Bisphosphonate therapy has been demonstrated to cause prolonged hypocalcaemia when given to patients with a history of parathyroidectomy....